This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
11/27/15 - 12:59:53 PM ET (BATS BZX Real-time Price)
VIVO Day's Range
VIVO 52 Week Range
VIVO Business Summary
Meridian Bioscience, Inc., a life science company, develops, manufactures, and distributes diagnostic test kits primarily for certain gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company operates through Diagnostics and Life Science segments.View VIVO key stats
Meridian Bioscience Inc - VIVO - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Meridian Bioscience Inc as a
Buy with a ratings score of B-.
Report Snippet: We rate MERIDIAN BIOSCIENCE INC (VIVO) a BUY. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, solid stock price performance, expanding profit margins and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.